These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6508478)

  • 21. Cognitive performances in parkinsonians before and after bromocriptine therapy.
    Piccirilli M; Piccinin GL; D'Alessandro P; Finali G; Piccolini C; Scarcella MG; Testa A
    Acta Neurol (Napoli); 1986 Jun; 8(3):167-72. PubMed ID: 3739763
    [No Abstract]   [Full Text] [Related]  

  • 22. [Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms].
    Goulley F; Wolmark Y; Bourdeix I; Chaumet-Riffaud PD
    Therapie; 1993; 48(3):233-8. PubMed ID: 7908147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
    Alegre M; Noé E; Martínez Lage JM
    Neurologia; 1997 Nov; 12(9):429. PubMed ID: 9471184
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of bromocriptine in the treatment of Parkinson's disease.
    Stern GM; Lees AJ; Shaw KM; Lander CM
    Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617
    [No Abstract]   [Full Text] [Related]  

  • 25. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
    Korczyn AD; Brooks DJ; Brunt ER; Poewe WH; Rascol O; Stocchi F
    Mov Disord; 1998 Jan; 13(1):46-51. PubMed ID: 9452325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bromocriptine].
    Raphael V
    Soins Gynecol Obstet Pueric Pediatr; 1989 Nov; (102):I-II. PubMed ID: 2617395
    [No Abstract]   [Full Text] [Related]  

  • 27. [The value of bromocriptine in the therapy of Parkinson disease].
    Castro-Caldas A
    Acta Med Port; 1981; 3(3):239-43. PubMed ID: 7325011
    [No Abstract]   [Full Text] [Related]  

  • 28. Improvement of L-dopa induced dyskinesia and of on-off phenomenon by bromocriptine.
    Ludin HP
    Acta Neurol Belg; 1980; 80(1):5-9. PubMed ID: 7361542
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism].
    Bøttcher J; Grøn U
    Ugeskr Laeger; 1981 Oct; 143(41):2648-9. PubMed ID: 7303288
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
    Mizuno Y; Yanagisawa N; Kuno S; Yamamoto M; Hasegawa K; Origasa H; Kowa H;
    Mov Disord; 2003 Oct; 18(10):1149-56. PubMed ID: 14534919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine.
    McGregor AM
    Practitioner; 1981 Oct; 225(1360):1471-5. PubMed ID: 7329935
    [No Abstract]   [Full Text] [Related]  

  • 32. Incontinence of urine with long-term bromocriptine therapy.
    Gopinathan G; Calne DB
    Ann Neurol; 1980 Aug; 8(2):204. PubMed ID: 6775584
    [No Abstract]   [Full Text] [Related]  

  • 33. Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
    Pezzoli G; Martignoni E; Pacchetti C; Angeleri VA; Lamberti P; Muratorio A; Bonuccelli U; De Mari M; Foschi N; Cossutta E
    Mov Disord; 1994 Jul; 9(4):431-6. PubMed ID: 7969210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromocriptine and lisuride in Parkinson's disease.
    Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
    Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bromocriptine (Parlodel) in parkinsonism].
    Pakkenberg H
    Ugeskr Laeger; 1978 May; 140(22):1297. PubMed ID: 653876
    [No Abstract]   [Full Text] [Related]  

  • 36. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH; Ha JH; Cho IS; Lee MC
    J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromocriptine.
    Sherman BM; Chapler FK
    J Iowa Med Soc; 1980 May; 70(5):209-10, 212. PubMed ID: 7189202
    [No Abstract]   [Full Text] [Related]  

  • 38. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
    Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine and endocrine imbalance.
    Hopkins S
    Nurs Mirror; 1981 Mar; 152(12):38. PubMed ID: 6908001
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.